Head-to-head · Cost-Efficiency Index
Fridays vs LaSara Medical Group
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fridays
Shoppers who want the annual-vs-monthly price difference disclosed upfront rather than discovering it after signup.
Visit FridaysLaSara Medical Group
Shoppers who want a hybrid in-person/telehealth GLP-1 option in Southern California and are comfortable prepaying a year for the lowest rate.
Visit LaSara Medical GroupThe verdict
Fridays and LaSara Medical Group tie on the Cost-Efficiency Index at 45/100, so neither wins outright on the numbers. For most shoppers we'd start with Fridays (ranked #464, a hair above #465) — Shoppers who want the annual-vs-monthly price difference disclosed upfront rather than discovering it after signup. But LaSara Medical Group is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fridays.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fridays | LaSara Medical Group |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 45/100 |
| Semaglutide / mo | $249/mo (starting dose, compounded) | $299/mo (starting dose, compounded) |
| Tirzepatide / mo | $359/mo (starting dose, compounded) | $399/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,988 | $3,588 |
| Tirzepatide / yr (modeled) | $4,308 | $4,788 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #464 | #465 |
Fridays
45/100Where the value is
- Explicitly discloses BOTH the annual-prepay rate and the true month-to-month rate on the same pricing page for every compounded product, rather than only advertising the lower prepay figure
- Bundles unlimited provider visits, group coaching, dietitian support, and a fitness app into the price with an explicit 'No membership fees, No sign up fees, No lab fees' statement
- Clinical services are sourced from a named, real network (OpenLoop Healthcare Partners) rather than an anonymous 'licensed providers' claim
The tradeoffs
- The advertised $150/$240 headline figures still require a full 12-month prepay to reach; a shopper who misses the '(annual prepay)' qualifier and compares it to a competitor's true monthly rate would understate Fridays' cost by 40-66%
- No compounding pharmacy is named anywhere on the pages read
LaSara Medical Group
45/100Where the value is
- Full, clean 4-tier pricing tables published for both drugs with exact dollar totals at every commitment length — real transparency, no gating behind intake
- Named clinical leadership: Medical Director Dr. Sunil Kurup and Founder/CEO John Snedegar
- Rare hybrid model — national telehealth plus an actual in-person Southern California option, alongside a broader hormone/peptide menu (TRT, NAD+, sermorelin, B12, enclomiphene)
The tradeoffs
- The lowest advertised per-month figures ($233 sema / $325 tirz) require a full 12-month prepay charged upfront ($2,795 / $3,895 at once) — the real month-to-month price is $299 / $399, 28-33% higher
- States served are not disclosed anywhere on the pricing pages despite the 'national telehealth' claim
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.